Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 40 of 40 entries
View as:

Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox

Phase: N/A Priority: Normal
NCT ID: NCT05476744 Org: User:
Start: 06/28/22 End: 03/30/23 Due: 03/30/24

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01458977 Org: User:
Start: 01/31/12 End: 02/28/14 Due: 02/28/15

Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention

Phase: N/A Priority: Normal
NCT ID: NCT04304053 Org: User:
Start: 03/18/20 End: 06/15/20 Due: 06/15/21

Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density

Phase: N/A Priority: Normal
NCT ID: NCT01966822 Org: User:
Start: 01/31/14 End: 10/31/15 Due: 10/31/16

A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI)

Phase: N/A Priority: Normal
NCT ID: NCT06519357 Org: User:
Start: 10/28/24 End: 03/31/26 Due: 03/31/27

Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT02487706 Org: User:
Start: 06/30/15 End: 07/31/15 Due: 07/31/16

Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)

Phase: N/A Priority: Normal
NCT ID: NCT06766825 Org: User:
Start: 02/07/25 End: 06/01/26 Due: 06/01/27

Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat

Phase: N/A Priority: Normal
NCT ID: NCT04322214 Org: User:
Start: 01/30/20 End: 04/30/20 Due: 04/30/21

Alternative Antibiotics for Syphilis

Phase: N/A Priority: Normal
NCT ID: NCT05069974 Org: User:
Start: 10/14/21 End: 12/31/25 Due: 12/31/26

EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS

Phase: N/A Priority: Normal
NCT ID: NCT03683524 Org: User:
Start: 11/19/18 End: 08/10/21 Due: 08/10/22

Plasma Exchange Therapy for Post- COVID-19 Condition: A Pilot, Randomized Double-Blind Study

Phase: N/A Priority: Normal
NCT ID: NCT05445674 Org: User:
Start: 09/22/22 End: 06/06/23 Due: 06/06/24

Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine

Phase: N/A Priority: Normal
NCT ID: NCT06185452 Org: User:
Start: 09/26/23 End: 06/30/25 Due: 06/30/26

Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT05562323 Org: User:
Start: 09/14/22 End: 08/31/26 Due: 08/31/27

Pilot Study to Assess the Impact of a Mobile Health Application (App) on Clinical Outcomes and Satisfaction of Older HIV-Infected Patients, as an Emerging Tool for Care, Education and Prevention.

Phase: N/A Priority: Normal
NCT ID: NCT04137016 Org: User:
Start: 12/15/16 End: 07/03/18 Due: 07/03/19

Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG

Phase: N/A Priority: Normal
NCT ID: NCT06690814 Org: User:
Start: 10/04/24 End: 11/01/24 Due: 11/01/25